Author: kwm107
-
D’Aquila Named Director of NUCATS
Richard D’Aquila, MD, the Howard Taylor Ricketts, MD, Professor of Medicine, has been named director of the Northwestern University Clinical and Translational Sciences (NUCATS) Institute, and senior associate dean for clinical and translational research.
-
Northwestern Team Develops New Antibody Test for COVID-19
Northwestern University scientists have developed a new method for testing for SARS-CoV-2 (the virus that causes COVID-19) antibodies, requiring only a single drop of blood collected from a simple finger prick.
-
New Center for Arrhythmia Research Launches
In the newly formed Center for Arrhythmia Research, teams of interdisciplinary clinicians and scientists will work together to discover both the underlying molecular causes of arrhythmias and new standards of care for their treatment.
-
First Wearable Device Continuously Tracks COVID-19 Symptoms
Investigators at Northwestern University and Shirley Ryan AbilityLab in Chicago have developed a novel wearable device and are creating a set of data algorithms specifically tailored to catch early signs and symptoms associated with COVID-19.
-
‘Caution Fatigue’ Could Dent Efforts to Stay Safe
Northwestern Medicine experts discuss the phenomenon of “caution fatigue,” where people may find it difficult to stay on high-risk alert after weeks of social distancing and isolation to stop the spread of COVID-19.
-
Older Adults Didn’t Think COVID-19 Would Affect Them
Many individuals in the highest risk category for COVID-19 because of multiple chronic health conditions didn’t think the disease would affect them and reported not changing their behavior at the beginning of Chicago’s outbreak, according to a new study.
-
Northwestern Scientists Awarded Top Honors for Achievement in Clinical Research
Northwestern University scientists received top honors from the Clinical Research Forum as part of its 2020 Top Ten Clinical Research Achievement Awards program, taking home the association’s highest honor and capturing more finalist nominations than any other institution.
-
Heart Disease, Racial Disparities and COVID-19
Northwestern Medicine cardiovascular experts discuss how racial disparities, including lower socioeconomic status and pre-existing cardiovascular conditions, can lead African-Americans to be at higher risk for contracting and dying from COVID-19.
-
COVID-19 Drug Trial Launches at Northwestern Medicine
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19, testing remdesivir, a novel anti-viral drug developed to treat Ebola, and which has also shown antiviral activity in coronaviruses.
-
Northwestern Scientists Transform Lab for COVID-19 Testing
A special COVID-19 testing team has been put in place at Northwestern, with the goal of at least quadrupling the number of tests processed at Northwestern Medicine hospitals — from about 90 per day to more than 350 per day — and in the process, greatly reducing test result turnaround times.
